Pathology and disease mechanisms in different stages of multiple sclerosis

Journal of the Neurological Sciences

Volumn 333, Issue 1-2, 2013, Pages 1-4

  Lassmann, Hans ^a  

^a Medical University of Vienna   (Austria)

Author keywords

Demyelination; Inflammation; Mitochondria; Multiple sclerosis; Neurodegeneration; Oxidative injury

Indexed keywords

3 NITROTYROSINE; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOCHONDRIAL DNA; MYELIN; MYELOPEROXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; AUTOPSY; B LYMPHOCYTE; BLOOD BRAIN BARRIER; BRAIN BIOPSY; BRAIN CIRCULATION; BRAIN CORTEX LESION; BRAIN DAMAGE; BRAIN INJURY; BRAIN VENTRICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; DEMYELINATION; DISEASE SEVERITY; GRAY MATTER; HUMAN; IMMUNOPATHOLOGY; INFLAMMATION; INFLAMMATORY CELL; MICROGLIA; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SPINAL CORD INJURY; T LYMPHOCYTE; TISSUE INJURY; WHITE MATTER; WHITE MATTER LESION;

DEMYELINATION; INFLAMMATION; MITOCHONDRIA; MULTIPLE SCLEROSIS; NEURODEGENERATION; OXIDATIVE INJURY;

BRAIN; DEMYELINATING DISEASES; DISEASE PROGRESSION; HUMANS; INFLAMMATION; MITOCHONDRIA; MULTIPLE SCLEROSIS; NERVE DEGENERATION; OXIDATIVE STRESS;

EID: 84884907805     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2013.05.010     Document Type: Review

References (52)

1. C.E. Lumsden The neuropathology of multiple sclerosis P.I. Vinken, G.W. Bruyn, Handbook of clinical neurology 9 1970 Elsevier New York 217 309
2. + T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction J Exp Med 192 2000 393 404
3. M.M. Esiri Multiple sclerosis: A quantitative and qualitative study of immunoglobulin-containing cells in the central nervous system Neuropathol Appl Neurobiol 6 1980 9 21
4. J.M. Frischer, S. Bramow, A. Dal Bianco, C. Lucchinetti, H. Rauschka, and M. Schmidbauer The relation between inflammation and neurodegeneration in multiple sclerosis Brain 132 2009 1175 1189
5. R. Hoftberger, F. Aboul-Enein, W. Brueck, C. Lucchinetti, M. Rodriguez, and M. Schmidbauer Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions Brain Pathol 14 2004 43 50
6. D.W. Holman, R.S. Klein, and R.M. Ransohoff The blood brain barrier, chemokines and multiple sclerosis Biochim Biophys Acta 2011 1812 220 230
7. J.W. Prineas The neuropathology of multiple sclerosis J.C. Koetsier, Handbook of Clinical Neurology 47 1985 Elsevier New York 337 395
8. C. Bjartmar, G. Kidd, S. Mork, R. Rudick, and B.D. Trapp Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients Ann Neurol 48 2000 893 901
9. J.W. Peterson, L. Bo, S. Mork, A. Chang, and B.D. Trapp Transsected neurites, apoptotic neurons and reduced inflammation in cortical multiple sclerosis lesions Ann Neurol 50 2001 389 400
10. A. Kutzelnigg, C.F. Lucchinetti, C. Stadelmann, W. Bruck, H. Rauschka, and M. Bergmann Cortical demyelination and diffuse white matter injury in multiple sclerosis Brain 128 2005 2705 2712
11. A. Cifelli, M. Arridge, P. Jezzard, M.M. Esiri, J. Palace, and P.M. Matthews Thalamic neurodegeneration in multiple sclerosis Ann Neurol 52 2002 650 653
12. C.P. Gilmore, J.J. Geurts, N. Eveangelou, J.C. Bot, R.A. van Schindel, and P.J. Pouwels Spinal cord grey matter lesions in multiple sclerosis detected by post-mortem high field MR imaging Mult Scler 15 2009 180 188
13. P. Patrikios, C. Stadelmann, A. Kutzelnigg, H. Rauschka, M. Schmidbauer, and H. Laursen Remyelination is extensive in a subset of multiple sclerosis patients Brain 129 2006 3165 3172
14. M. Albert, J. Antel, W. Brück, and C. Stadelmann Extensive cortical remyelination in patients with chronic multiple sclerosis Brain Pathol 17 2007 129 138
15. B. Kornek, M. Storch, R. Weissert, E. Wallstroem, A. Stefferl, and T. Olsson Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive and remyelinated lesions Amer J Pathol 157 2000 267 276
16. J.W. Prineas, R.O. Barnard, T. Revesz, E.E. Kwon, L.R. Sharer, and E.S. Cho Multiple sclerosis. Pathology of recurrent lesions Brain 116 1993 681 693
17. S. Bramow, J.M. Frischer, H. Lassmann, N. Koch-Henriksen, C.F. Lucchinetti, and P.S. Sørensen Demyelination versus remyelination in progressive multiple sclerosis Brain 133 2010 2983 2998
18. F.D. Lublin, and S.C. Reingold Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis Neurology 46 1996 907 911
19. H. Wiendl, and R. Hohlfeld Multiple sclerosis therapeutics: unexpected outcomes clouding undisputed successes Neurology 72 2009 1008 1015
20. P.S. Giacomini, P.J. Darlington, and A. Bar-Or Emerging multiple sclerosis disease-modifying therapies Curr Opin Neurol 22 2009 226 232
21. C.F. Lucchinetti, B.F.G. Popescu, R.F. Bunyan, N.M. Moll, S.F. Roemer, and H. Lassmann Inflammatory cortical demyelination in early multiple sclerosis N Engl J Med 365 23 2011 2188 2197
22. R. Magliozzi, O.W. Howell, C. Reeves, F. Roncaroli, R. Nicholas, and B. Serafini A gradient of neuronal loss and meningeal inflammation in multiple sclerosis Ann Neurol 68 2010 477 493
23. R. Magliozzi, O. Howell, A. Vora, B. Serafini, R. Nicholas, and M. Puopolo Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology Brain 130 2007 1089 1104
24. S. Hochmeister, R. Grundtner, J. Bauer, B. Engelhardt, R. Lyck, and G. Gordon Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis J Neuropathol Exp Neurol 65 2006 855 865
25. B. Serafini, B. Rosicarelli, R. Magliozzi, E. Stigliano, and F. Aloisi Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis Brain Pathol 14 2004 164 174
26. O.W. Howell, C.A. Reeves, R. Nicholas, D. Carassiti, B. Radotra, and S.M. Gentleman Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis Brain 134 2011 2755 2771
27. K. Ozawa, G. Suchanek, H. Breitschopf, W. Brück, H. Budka, and K. Jellinger Patterns of oligodendroglia pathology in multiple sclerosis Brain 117 1994 1311 1322
28. W. Brück, Ph. Porada, S. Poser, P. Rieckmann, F. Hanefeld, and H.A. Kretschmer Monocyte/macrophage differentiation in early multiple sclerosis Ann Neurol 38 1995 788 796
29. J.W. Prineas, E.E. Kwon, E.S. Cho, L.R. Sharer, M.H. Barnett, and E.L. Oleszak Immunopathology of secondary-progressive multiple sclerosis Ann Neurol 50 2001 646 657
30. L. Bo, C.A. Vedeler, H.I. Nyland, B.D. Trapp, and S.J. Mork Subpial demyelination in the cerebral cortex of multiple sclerosis patients J Neuropathol Exp Neurol 62 2003 723 732
31. M.T. Fischer, I. Wimmer, R. Höftberger, S. Gerlach, L. Haider, and T. Zrzavy Disease-specific molecular events in cortical multiple sclerosis lesions Brain 2013 [in press, Electronic publication ahead of print]
32. N.M. Moll, A.M. Rietsch, A.J. Ransohoff, M.B. Cossoy, D. Huang, and F.S. Eichler Cortical demyelination in PML and MS: similarities and differences Neurology 70 2008 336 343
33. S. Choi, O.W. Howell, D. Carassiti, R. Magliozzi, D. Gveric, and P.A. Muraro Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis Brain 135 2012 2925 2937
34. J. Kolasinski, C.J. Stagg, S.A. Chance, G.C. DeLuca, M.M. Esiri, and E.H. Chang A combined post-mortem MRI and quantitative histological study of multiple sclerosis pathology Brain 135 2012 2938 2951
35. H. Lassmann Cortical lesions in multiple sclerosis: inflammation versus neurodegeneration Brain 135 2012 2904 2905
36. N. Evangelou, D. Konz, M.M. Esiri, S. Smith, J. Palace, and P.M. Matthews Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis Brain 123 2000 1845 1849
37. G.C. DeLuca, K. Williams, N. Evangelou, G.C. Ebers, and M.M. Esiri The contribution of demyelination to axonal loss in multiple sclerosis Brain 129 2006 1507 1516
38. C. Wegner, M.M. Esiri, S.A. Chance, J. Palace, and P.M. Matthews Neocortical neuronal, synaptic, and glial loss in multiple sclerosis Neurology 67 2006 960 967
39. C. Lucchinetti, W. Brück, J. Parisi, B. Scheithauer, M. Rodriguez, and H. Lassmann Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination Ann Neurol 47 2000 707 717
40. H. Lassmann, and J. van Horssen The molecular basis of neurodegeneration in multiple sclerosis FEBS Lett 585 23 2011 3715 3723
41. D. Mahad, I. Ziabreva, H. Lassmann, and D. Turnbull Mitochondrial defects in acute multiple sclerosis lesions Brain 131 2008 1722 1735
42. A.H. Cross, P.T. Manning, R.M. Keeling, R.E. Schmidt, and T.P. Misko Peroxynitrite formation within the central nervous system in active multiple sclerosis J Neuroimmunol 88 1998 45 56
43. J.S.H. Liu, M.L. Zhao, C.F. Brosnan, and S.C. Lee Expression of indicible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions Amer J Pathol 158 2001 2057 2066
44. M.T. Fischer, R. Sharma, J. Lim, L. Haider, J. Frischer, and J. Drexhage NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury Brain 135 2012 886 899
45. C. Marik, P. Felts, J. Bauer, H. Lassmann, and K.J. Smith Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain 130 2007 2800 2815
46. E. Gray, T.L. Thomas, S. Betmouni, N. Scolding, and S. Love Elevated myeloperoxidase activity in white matter in multiple sclerosis Neurosci Lett 442 2008 195 198
47. L. Haider, M.T. Fischer, J.M. Frischer, J. Bauer, R. Höftberger, and G. Botond Oxidative damage and neurodegeneration in multiple sclerosis lesions Brain 134 2011 1914 1924
48. B. Hallgren, and P. Sourander The effect of age on the non-haemin iron in the human brain J Neurochem 3 1958 41 51
49. S.W. Hulet, S. Powers, and J.R. Connor Distribution of transferrin and ferritin binding in normal and multiple sclerotic human brain J Neurol Sci 165 1999 48 55
50. E. Graf, J.R. Mahoney, R.G. Bryant, and J.W. Eaton Iron-catalyzed hydroxyl radical formation J Biol Chem 259 1984 3620 3624
51. F. Bagnato, S. Hametner, B. Yao, P. van Gelderen, H. Merkle, and F.K. Cantor Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla Brain 134 2011 3602 3615
52. G.R. Campbell, I. Ziabreva, A.K. Reeve, K.J. Krishnan, R. Reynolds, and O. Howell Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis Ann Neurol 69 2011 481 492